Login
Certara, Inc. logo

Certara, Inc.

certara.com

Certara Inc (NASDAQ: CERT) is a biosimulation and drug development software company that provides model-informed drug development platforms and regulatory science services to pharmaceutical, biotechnology, and medical device companies. The filing excerpts provided do not contain sufficient detail to fully characterize revenue streams, segment splits, customer counts, geographic mix, or competitive positioning from the FY2025 10-K filed 2026-02-26. Based solely on the available filing text, specific financial metrics, product names, customer concentration figures, and competitor names cannot be confirmed and are therefore omitted per source-grounding requirements.

Financial Snapshot

Revenue
TTM
$408.5M
Gross Margin
TTM
61.77%
Net Income
TTM
-$68.40M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
255.06%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$966.5M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$58.37M

Stock Price

Loading...
Market Cap: $1.2725 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support